Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

The role of vaccination, antiorthopoxvirus drug, and social cooperativity in a mathematical model of smallpox control.

Finin P, Kosaraju A, Rose E, Rubin H.

Biosecur Bioterror. 2013 Mar;11(1):59-72. doi: 10.1089/bsp.2012.0037. Epub 2013 Mar 26.

PMID:
23530860
2.

Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.

Duraffour S, Andrei G, Snoeck R.

IDrugs. 2010 Mar;13(3):181-91. Review.

PMID:
20191435
3.

Under scrutiny: smallpox vaccine recommendations.

Kemper AR, Davis MM.

Expert Opin Pharmacother. 2003 Aug;4(8):1207-14. Review.

PMID:
12877631
4.

Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.

Sato H.

Environ Health Prev Med. 2011 Sep;16(5):281-9. doi: 10.1007/s12199-010-0200-z. Epub 2010 Dec 21. Review.

5.

The effect of social mixing controls on the spread of smallpox--a two-level model.

Kress M.

Health Care Manag Sci. 2005 Nov;8(4):277-89. Review.

PMID:
16379411
6.

Smallpox antiviral drug development: satisfying the animal efficacy rule.

Jordan R, Hruby D.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):277-89. Review.

PMID:
16597208
7.

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.

Bray M.

Antiviral Res. 2003 Apr;58(2):101-14. Review.

PMID:
12742570
8.

[Smallpox--in the past or not?].

Kuljić-Kapulica N.

Srp Arh Celok Lek. 2004 Jul-Aug;132(7-8):272-6. Review. Serbian.

9.

Smallpox and bioterrorism: public-health responses.

Hull HF, Danila R, Ehresmann K.

J Lab Clin Med. 2003 Oct;142(4):221-8. Review.

PMID:
14625527
10.

The new cell culture smallpox vaccine should be offered to the general population.

Bicknell W, James K.

Rev Med Virol. 2003 Jan-Feb;13(1):5-15. Review.

PMID:
12516058
11.

Ring vaccination versus mass vaccination in event of a smallpox attack.

Lau CY, Wahl B, Foo WK.

Hawaii Med J. 2005 Feb;64(2):34-6, 53. Review.

PMID:
15871566
12.

Smallpox: clinical features, prevention, and management.

Guharoy R, Panzik R, Noviasky JA, Krenzelok EP, Blair DC.

Ann Pharmacother. 2004 Mar;38(3):440-7. Epub 2004 Jan 30. Review.

PMID:
14755066
13.

Remaining questions about clinical variola major.

Lane JM.

Emerg Infect Dis. 2011 Apr;17(4):676-80. doi: 10.3201/eid1704.101960. Review.

14.

Preventing second-generation infections in a smallpox bioterror attack.

Kaplan EH.

Epidemiology. 2004 May;15(3):264-70. Review.

PMID:
15097005
15.

Smallpox: a review of clinical disease and vaccination.

Lofquist JM, Weimert NA, Hayney MS.

Am J Health Syst Pharm. 2003 Apr 15;60(8):749-56; quiz 757-8. Review.

PMID:
12749161
16.

[Small pox--infection, therapy and anaesthesiological management (part 1)].

Langefeld TW, Engel J, Menges T, Hempelmann G.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Jul;38(7):445-55. Review. German.

PMID:
12822115
17.

Prospects for the eradication of infectious diseases.

Stuart-Harris C.

Rev Infect Dis. 1984 May-Jun;6(3):405-11. Review.

PMID:
6377445
18.

Smallpox: a potential agent of bioterrorism.

Whitley RJ.

Antiviral Res. 2003 Jan;57(1-2):7-12. Review.

PMID:
12615298
19.

Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies.

Lee VJ, Lye DC, Wilder-Smith A.

BMC Med. 2009 Dec 10;7:76. doi: 10.1186/1741-7015-7-76. Review.

20.

Smallpox and smallpox vaccination: neurological implications.

Booss J, Davis LE.

Neurology. 2003 Apr 22;60(8):1241-5. Review.

PMID:
12707424

Supplemental Content

Support Center